Pliant Therapeutics Inc

NASDAQ:PLRX   3:59:33 PM EDT
5.51
+0.25 (+4.75%)
Products

Pliant Therapeutics Receives FDA Fast Track Designation For PLN-74809 For The Treatment Of Idiopathic Pulmonary Fibrosis

Published: 05/03/2022 12:50 GMT
Pliant Therapeutics Inc (PLRX) - Pliant Therapeutics Receives FDA Fast Track Designation for Pln-74809 for the Treatment of Idiopathic Pulmonary Fibrosis.
Pliant Therapeutics Receives FDA Fast Track Designation for Pln-74809 for the Treatment of Idiopathic Pulmonary Fibrosis.